A team of researchers affiliated with several entities in Thailand, working with two colleagues from the US and two from Canada, has developed an mRNA COVID-19 vaccine that can be safely refrigerated for up to three months before use. The team has named it ChulaCov19. In their paper published in the journal Nature Microbiology, the …
Research in Thailand develops long shelf life COVID-19 vaccine Read More »
The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine last Wednesday in what appears to be a world first. www.pbs.org/newshour/world/china-begins-administering-inhalable-covid-19-vaccine-boosters? The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, according to an announcement on an official city social …
A new generation of COVID-19 vaccines that can be inhaled or sprayed up the nose—instead of taken by injection—will begin rolling out in Asia, though just how effective they are remains to be seen. Regulators in China and India have greenlighted distribution of vaccines delivered through the mouth or nose, a delivery that scientists say …
Billion-dollar plan Almost as if to make up for the lost Trump year during the pandemic, the White House has put together an ambitious new plan with a $65.3 billion price tag that could transform the way the United States responds to pandemics by vastly accelerating vaccine development, testing, and production. But is the plan …
According to a provisional report, India’s vaccine drive surpassed the milestone of administering 55 crore and set a record in the last 24 hours. However, many vaccine doses provided to states and union territories remain unused. The past 24 hours saw 88.13 lakh doses administered, taking the cumulative number of shots in arms to 554,730,609 …
Vaccine drive crosses 55 crore, unused doses remain Read More »
BioNTech gained prominent public attention for its collaboration with Pfizer which produced a COVID-19 vaccine using mRNA technology. They have once again hit the headlines – this time setting their sights on malaria. BioNTech’s malaria project is part of the ‘eradicateMalaria’ initiative, led by the kENUP Foundation, to accelerate the eradication of the mosquito-borne disease. …
mRNA vaccine in development for malaria – too soon for hype? Read More »
An expert government panel is in talks regarding the BioNTech / Pfizer vaccine, Union Health Minister Mankush Mandaviya told the Lok Sabha on Friday. The Minister said “an expert group of the Indian government is still in talks with Pfizer over COVID vaccine supply.” United States State Department spokesperson Ned Price has announced that the …
An estimated 3.5 million children missed out on their first dose of diphtheria-tetanus-pertussis combined vaccine (DTP-1) in India in 2020, according to data from the World Health Organisation (WHO). Three million more children missed their first dose of the measles vaccination. Such were the effects of the initial wave of the COVID-19 pandemic that health …
The Pfizer/BioNTech vaccine against COVID-19 has registered a lower level of efficacy in preventing the Delta variant first identified in India, according to new data from Israel. Effectiveness of the vaccine has dropped to 64 percent in preventing infection as the Delta variant spreads in Israel, now accounting for ninety percent of the country’s cases. …
Pfizer/BioNTech vaccine: Less effective against Delta variant? Read More »
Monday saw India administer a record 8.3 million doses of COVID-19 vaccine. Nonetheless, concerns remain surrounding the pace of an inoculation campaign once billed by Prime Minister Narendra Modi as set to be the largest in the world. “Today’s record-breaking vaccination numbers are gladdening,” Modi tweeted. “The vaccine remains our strongest weapon to fight COVID-19. …
Inoculation record achieved, but concerns remain Read More »
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
